High-Throughput Sequencing and Estimated Relapse Risk in Patients With Sézary Syndrome.
作者信息
Weiner Jeffrey D, Weiner David M, Benoit Bernice, Teague Jessica E, Clark Rachael A, Rook Alain H
机构信息
Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
出版信息
JAMA Dermatol. 2025 Sep 3. doi: 10.1001/jamadermatol.2025.3054.
Abstract
摘要
相似文献
1
High-Throughput Sequencing and Estimated Relapse Risk in Patients With Sézary Syndrome.蕈样肉芽肿患者的高通量测序与估计复发风险
JAMA Dermatol. 2025 Sep 3. doi: 10.1001/jamadermatol.2025.3054.
2
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon.抗 CCR4 抗体联合 I 型干扰素引发 Sézary 综合征中单核细胞的激活。
Blood Adv. 2024 May 28;8(10):2384-2397. doi: 10.1182/bloodadvances.2023010043.
3
Case report of non-gene editing CD7 CAR T cell therapy in CD7 Sézary syndrome: preclinical validation and first-in-human use.非基因编辑的CD7嵌合抗原受体T细胞疗法治疗CD7蕈样肉芽肿综合征的病例报告：临床前验证及首次人体应用
Front Immunol. 2025 Aug 1;16:1604490. doi: 10.3389/fimmu.2025.1604490. eCollection 2025.
4
Interventions for minimal change disease in adults with nephrotic syndrome.成人肾病综合征微小病变病的干预措施。
Cochrane Database Syst Rev. 2022 Mar 1;3(3):CD001537. doi: 10.1002/14651858.CD001537.pub5.
5
Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.硫唑嘌呤和6-巯基嘌呤用于维持克罗恩病手术诱导的缓解状态
Cochrane Database Syst Rev. 2014 Aug 1;2014(8):CD010233. doi: 10.1002/14651858.CD010233.pub2.
6
Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome.解析皮肤 T 细胞淋巴瘤中的肿瘤细胞进化：蕈样肉芽肿和 Sezary 综合征中的不同分化轨迹。
J Invest Dermatol. 2024 May;144(5):1088-1098. doi: 10.1016/j.jid.2023.10.018. Epub 2023 Nov 28.
7
Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Español de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee.嵌合抗原受体T细胞（CAR-T）疗法时代小儿急性淋巴细胞白血病的移植后复发。西班牙血液移植与细胞治疗协作组（GETH-TC）儿科委员会的多中心分析
Cytotherapy. 2025 Apr;27(4):438-445. doi: 10.1016/j.jcyt.2024.11.016. Epub 2024 Dec 2.
8
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.成人肾病综合征中原发性膜性肾病的免疫抑制治疗。
Cochrane Database Syst Rev. 2021 Nov 15;11(11):CD004293. doi: 10.1002/14651858.CD004293.pub4.
9
Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis.维持克罗恩病手术诱导缓解的干预措施：一项网状Meta分析
Cochrane Database Syst Rev. 2019 Sep 12;9(9):CD013210. doi: 10.1002/14651858.CD013210.pub2.
10
High Ultra-Processed Food Consumption Is Associated with Clinical Exacerbation in Patients with Crohn's Disease in Remission: A Prospective Cohort Study.高超加工食品消费与缓解期克罗恩病患者的临床病情加重相关：一项前瞻性队列研究
Dig Dis. 2025 May 20:1-10. doi: 10.1159/000546486.
本文引用的文献
1
Longitudinal ultra-sensitive mutation burden sequencing for precise minimal residual disease assessment in AML.用于 AML 精准微小残留病灶评估的纵向超高敏突变负担测序。
Nat Commun. 2024 Nov 14;15(1):9853. doi: 10.1038/s41467-024-54254-6.
2
Immunosequencing applications in cutaneous T-cell lymphoma.免疫测序在皮肤 T 细胞淋巴瘤中的应用。
Front Immunol. 2023 Dec 21;14:1300061. doi: 10.3389/fimmu.2023.1300061. eCollection 2023.
3
High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.高通量测序 T 细胞受体 β 基因可鉴定侵袭性早期蕈样肉芽肿。
Sci Transl Med. 2018 May 9;10(440). doi: 10.1126/scitranslmed.aar5894.
4
Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma.采用高通量 TCR 测序技术监测皮肤 T 细胞淋巴瘤的微小残留病灶。
Sci Transl Med. 2013 Dec 4;5(214):214ra171. doi: 10.1126/scitranslmed.3007420.
5
Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia.使用共识引物和高通量IGH 测序进行微小残留病定量可预测慢性淋巴细胞白血病移植后的复发。
Leukemia. 2013 Aug;27(8):1659-65. doi: 10.1038/leu.2013.52. Epub 2013 Feb 19.
6
Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia.缓解诱导治疗结束时微小残留病水平低对儿童急性淋巴细胞白血病的临床意义。
Blood. 2010 Jun 10;115(23):4657-63. doi: 10.1182/blood-2009-11-253435. Epub 2010 Mar 19.
Zotero 插件